Cure Today

Educated Patient® Breast Cancer Summit at MBCC HER2-Positive Metastatic Disease Presentation: March 4, 2023

Outcomes for patients with metastatic HER2-positive breast cancer have improved as a result of research helping health care providers to understand the mechanisms of the protein, which has led to the ...
Nasdaq

Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform

ALPHARETTA, Ga., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
Seeking Alpha

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr.
Cure Today

Educated Patient® Breast Cancer Summit at MBCC Early-Stage HER2-Positive Presentation: March 4, 2023

Knowing whether patients with early-stage breast cancer have HER2-positive disease allows them to receive the appropriate treatment for an aggressive type of cancer, an expert explained. Early-stage ...